Albin Moschner - Nuveen SP Independent Director
| SPXX Etf | USD 17.76 0.16 0.89% |
| Age | 69 |
| Tenure | 8 years |
| Phone | 312-917-7700 |
| Web | https://www.nuveen.com/cef/Product/Overview.aspx?FundCode=SPXX |
Albin Moschner Latest Insider Activity
Tracking and analyzing the buying and selling activities of Albin Moschner against Nuveen SP etf is an integral part of due diligence when investing in Nuveen SP. Albin Moschner insider activity provides valuable insight into whether Nuveen SP is net buyers or sellers over its current business cycle. Note, Nuveen SP insiders must abide by specific rules, including filing SEC forms every time they buy or sell Nuveen SP'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Albin Moschner over six months ago Insider Trading | ||
Albin Moschner over six months ago Insider Trading |
Nuveen SP Management Efficiency
The company has return on total asset (ROA) of 0.4 % which means that it generated a profit of $0.4 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (7.91) %, meaning that it created substantial loss on money invested by shareholders. Nuveen SP's management efficiency ratios could be used to measure how well Nuveen SP manages its routine affairs as well as how well it operates its assets and liabilities.Similar Fund Executives
| Showing other executives | One Year Return | ||
| Robert Fairbairn | BlackRock Science Tech | 56 | |
| Stayce Harris | BlackRock Health Sciences | 62 | |
| CFA CFA | BlackRock Health Sciences | N/A | |
| Xiang Liu | BlackRock Health Sciences | N/A | |
| George Batejan | Columbia Seligman Premium | 67 | |
| Cynthia Egan | Blackrock Enhanced Capital | 66 | |
| Robert Fairbairn | BlackRock Health Sciences | 56 | |
| Scott Wennerholm | Eaton Vance Tax | 62 | |
| Edward Perkin | Eaton Vance Tax | 49 | |
| Daniel Beckman | Columbia Seligman Premium | 57 | |
| C Ward | Cohen And Steers | 74 | |
| Scott Wennerholm | Eaton Vance Tax | 62 | |
| Richard Froio | Eaton Vance Tax | 53 | |
| Cynthia Egan | BlackRock Science Tech | 66 | |
| Catherine Lynch | Blackrock Enhanced Capital | 60 | |
| Catherine Lynch | BlackRock Health Sciences | 60 | |
| Dana DeVivo | Cohen And Steers | 39 | |
| W Kester | BlackRock Science Tech | 70 | |
| Daphne Richards | Cohen And Steers | 54 | |
| Stayce Harris | Blackrock Enhanced Capital | N/A | |
| Deidre Walsh | Eaton Vance Tax | 50 | |
Management Performance
| Return On Equity | -7.91 | ||||
| Return On Asset | 0.4 |
Nuveen SP 500 Money Managers
| Mark Winget, Vice President Assistant Secretary | ||
| E Wickerham, Vice President Controller | ||
| Deann Morgan, Vice President | ||
| Robert Young, Independent Director | ||
| Jack Evans, Independent Director | ||
| David Lamb, Chief Administrative Officer | ||
| Mark Czarniecki, Vice President Assistant Secretary | ||
| Cedric Antosiewicz, Chief Administrative Officer | ||
| Judith Stockdale, Independent Director | ||
| William Siffermann, Vice President | ||
| William Meyers, Vice President | ||
| Michael Perry, Vice President | ||
| Jacques Longerstaey, Vice President | ||
| Matthew Thornton, Independent Director | ||
| Margaret Wolff, Independent Director | ||
| Brian Lockhart, Vice President | ||
| Diana Gonzalez, Vice President Assistant Secretary | ||
| Gifford Zimmerman, Chief Compliance Officer, Vice President | ||
| Nathaniel Jones, Vice President Treasurer | ||
| Terence Toth, Independent Chairman of the Board | ||
| Carole Stone, Independent Director | ||
| Jon Meissner, Vice President, Assistant Secretary | ||
| Christopher Rohrbacher, Vice President Assistant Secretary | ||
| Walter Kelly, Chief Compliance Officer, Vice President | ||
| John Nelson, Independent Director | ||
| Albin Moschner, Independent Director | ||
| Kevin McCarthy, Vice President, Assistant Secretary | ||
| William Hunter, Independent Director | ||
| Tina Lazar, Vice President |
Nuveen Etf Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right etf is not an easy task. Is Nuveen SP a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -7.91 | ||||
| Return On Asset | 0.4 | ||||
| Operating Margin | 40.69 % | ||||
| Current Valuation | 286.47 M | ||||
| Shares Outstanding | 17.19 M | ||||
| Shares Owned By Institutions | 28.53 % | ||||
| Number Of Shares Shorted | 213.11 K | ||||
| Price To Earning | 19.35 X | ||||
| Price To Book | 1.09 X | ||||
| Price To Sales | 64.63 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Nuveen Etf
Nuveen SP financial ratios help investors to determine whether Nuveen Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nuveen with respect to the benefits of owning Nuveen SP security.